Chemomab Therapeutics to Present at H.C. Wainwright 28th Annual Global Investor Conference
Yahoo Finance · Aug 31, 2026 · Chemomab Therapeutics Ltd DRC (CMMB)
TEL AVIV, Israel, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Chemomab Therapeutics Ltd. (Nasdaq: CMMB) (Chemomab), a clinical stage biotechnology company developing innovative therapeutics for immune-fibrotic diseases with high unmet need, today announced that Chief Executive Officer Dr. Adi Mor will deliver a corporate presentation at the H.C. Wainwright 28th Annual Global Investment Conference. Dr. Mor’s prerecorded presentation will be webcast and will be available starting on September 11, 2026 at 7:
Not investment advice. Cached headline, not a full reprint.